Reinspection lands Alexion with 483 for Soliris plant
A US FDA reinspection of Alexion’s Rhode Island facility hit with a warning letter last year has resulted in a Form 483 with three observations.
Archives for August 25, 2014
EMD Millipore to supply Samsung's Yervoy plant in 10-year deal
EMD Millipore has been contracted to supply raw materials to the Samsung Biologics plant where ingredients for BM-S’ anticancer monoclonal antibody Yervoy (ipilimumab) are made.
Janssen acquires Fynomer mAb platform in Covagen buy-out
Johnson & Johnson subsidiary Janssen has acquired monoclonal antibody (mAb) platform FynomAb through its purchase of private Swiss biopharma company Covagen.